Laura Damme is VP at TransMedics Group, Inc. (TMDX). They have made 1 open-market trade across 1 company since 2022, most recently 2023-02-20.
CIK 0001784433
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TMDX | 5,685 | $403K |
Shares reported on the most recent Form 4, priced at the 2023-02-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMDX | SELL | 2022-12-14 | 2022-12-16 | $60.88 | $1.3M | +1.9% | +8.8% | +28.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.